Page last updated: 2024-08-25

honokiol and Head and Neck Neoplasms

honokiol has been researched along with Head and Neck Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbiser, JL; Beitler, JJ; Chen, AY; Chen, G; Chen, Z; Chen, ZG; Deng, X; Huang, W; Kim, S; Magliocca, K; Nannapaneni, S; Patel, MR; Qian, G; Saba, NF; Shin, DM; Wang, X; Zhang, J1
Gupta, NA; Katiyar, SK; Prasad, R; Singh, T; Velu, SE; Xu, S1
Katiyar, SK1
Arbiser, JL; Bhola, NE; Cai, Q; Grandis, JR; Joyce, SC; Leeman-Neill, RJ; Neill, DB; Thomas, SM1

Reviews

1 review(s) available for honokiol and Head and Neck Neoplasms

ArticleYear
Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.
    Molecules (Basel, Switzerland), 2016, Nov-24, Volume: 21, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Head and Neck Neoplasms; Humans; Lignans; Magnolia; Polyphenols; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Tea; Vitis

2016

Other Studies

3 other study(ies) available for honokiol and Head and Neck Neoplasms

ArticleYear
Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 02-15, Volume: 24, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Squamous Cell; Cell Line, Tumor; Chemoradiotherapy; Down-Regulation; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lignans; Mice, Nude; Radiation-Sensitizing Agents; Survivin; Tumor Burden; Xenograft Model Antitumor Assays

2018
Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
    Oncotarget, 2015, Aug-28, Volume: 6, Issue:25

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Biphenyl Compounds; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cell Survival; Dose-Response Relationship, Drug; ErbB Receptors; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Lignans; Magnolia; Mice; Mice, Nude; Molecular Docking Simulation; Phytotherapy; Plant Extracts; Signal Transduction; Sirolimus

2015
Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, May-01, Volume: 16, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cetuximab; Dose-Response Relationship, Drug; Drug Synergism; Drugs, Chinese Herbal; ErbB Receptors; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Lignans; Mice; Mice, Nude; Quinazolines; Signal Transduction; Xenograft Model Antitumor Assays

2010